Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Oct 15, 2020; 12(10): 1133-1145
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1133
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1133
Figure 2 Comparison of disease-free survival rates between open pancreatic resection and minimally invasive approaches for treating patients with nonfunctioning pancreatic neuroendocrine tumors.
DFS: Disease-free survival; MIS: Minimally invasive surgery; NF-PNET: Nonfunctioning-pancreatic neuroendocrine tumors.
- Citation: Kim J, Hwang HK, Lee WJ, Kang CM. Minimally invasive vs open pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors. World J Gastrointest Oncol 2020; 12(10): 1133-1145
- URL: https://www.wjgnet.com/1948-5204/full/v12/i10/1133.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i10.1133